Company Profile
Year Established :
1958
Total Assets(USD) :
35,000,000 To 39,999,999
Total Number of Staff :
250 to 299
Main Competitive Advantages :
International Approvals/Standards,Experienced R&D Staff,Production capacity
Business Type :
Manufacturer,Trading Company
Annual Turnover(USD) :
15,000,000 To 19,999,999
Main Sales Markets :
North America,Central/South America,Western Europe,Eastern Europe,Asia,Middle East
Main Product Categorise :
Active Pharmaceutical Ingredients,Intermediates
Chongqing Southwest Pharmaceutical Co., Ltd. was founded in 1958, with more than 60 years of experience in the development and production of APIs, preparations and pharmaceutical and chemical intermediates. In 2005, the enterprise production base was relocated to Chongqing Jiangjin Degan Industrial Park. The new production base covers an area of 130000 square meters and employs more than 300, consists of 3 API workshops and a solid preparation workshop. We have passed National GMP inspections and FDA site inspection (Procaine HCL& Benzocaine). Nowadays, we are the manufacturer of 12 GMP approved APIs and intermediates, Procaine hydrochloride,Benzocaine, Nifuratel, Gastrodin,Olopatadine hydrochloride,
Cholecalciferol-cholesterol, Meprobamate, Gastrodin, Primaquine phosphate, Piperaquine phosphate, Chloroquine phosphate, Nifuratel, Fenofibrate, Naproxen are our main products.